Previous close | 120.50 |
Open | 120.40 |
Bid | 108.90 x N/A |
Ask | 109.20 x N/A |
Day's range | 106.50 - 120.40 |
52-week range | 81.64 - 153.00 |
Volume | |
Avg. volume | 89,003 |
Market cap | 1.993B |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.60 |
Earnings date | 30 July 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 151.80 |
Amidst a backdrop of robust gains across major European stock indices, including a notable 4.28% rise in Germany's DAX, investors are showing renewed optimism. This positive sentiment is particularly relevant when considering growth companies in Germany with high insider ownership, as these firms often benefit from aligned interests between shareholders and management, fostering strong corporate governance and potentially enhancing shareholder value.
Redcare Pharmacy ( ETR:RDC ) First Quarter 2024 Results Key Financial Results Revenue: €560.2m (up 51% from 1Q 2023...
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...